NANOVIRICIDES, INC. Quarterly Common Stock, Shares, Issued from Q2 2011 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Nanoviricides, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q2 2011 to Q2 2024.
  • Nanoviricides, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 13.1M shares, a 12.4% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 13.1M +1.45M +12.4% Jun 30, 2024 10-K 2024-09-27
Q1 2024 11.8M +147K +1.26% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 11.8M +144K +1.24% Dec 31, 2023 10-Q 2024-02-14
Q3 2023 11.7M +136K +1.17% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 11.7M +106K +0.92% Jun 30, 2023 10-K 2024-09-27
Q1 2023 11.7M +112K +0.97% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 11.6M +100K +0.87% Dec 31, 2022 10-Q 2023-02-14
Q3 2022 11.6M +84.8K +0.74% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 11.6M +77K +0.67% Jun 30, 2022 10-K 2023-10-13
Q1 2022 11.6M +49.8K +0.43% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 11.5M +857K +8.03% Dec 31, 2021 10-Q 2022-02-14
Q3 2021 11.5M +859K +8.06% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 11.5M +2.43M +26.8% Jun 30, 2021 10-K 2022-10-13
Q1 2021 11.5M +3.83M +49.9% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 10.7M +6.81M +176% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 10.7M +6.81M +177% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 9.08M +5.24M +136% Jun 30, 2020 10-K 2021-10-12
Q1 2020 7.67M -69.1M -90% Mar 31, 2020 10-Q 2020-06-22
Q4 2019 3.87M -65.6M -94.4% Dec 31, 2019 10-Q 2020-02-14
Q3 2019 3.85M -65.5M -94.4% Sep 30, 2019 10-Q 2019-11-15
Q2 2019 3.84M -65.3M -94.4% Jun 30, 2019 10-K 2020-10-13
Q1 2019 76.7M +7.75M +11.2% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 69.5M +6.13M +9.67% Dec 31, 2018 10-Q 2019-02-14
Q3 2018 69.4M +6.05M +9.55% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 69.2M +5.86M +9.26% Jun 30, 2018 10-K 2019-08-23
Q1 2018 69M +5.91M +9.38% Mar 31, 2018 10-Q 2018-05-21
Q4 2017 63.4M +4.91M +8.41% Dec 31, 2017 10-Q 2018-02-20
Q3 2017 63.3M +5.13M +8.82% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 63.3M +5.13M +8.81% Jun 30, 2017 10-K 2018-10-12
Q1 2017 63.1M +5.1M +8.8% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 58.5M +636K +1.1% Dec 31, 2016 10-Q 2017-02-14
Q3 2016 58.2M +617K +1.07% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 58.2M +938K +1.64% Jun 30, 2016 10-K 2017-09-28
Q1 2016 58M +823K +1.44% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 57.8M +1.26M +2.23% Dec 31, 2015 10-Q 2016-02-09
Q3 2015 57.6M +1.05M +1.86% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 57.2M +2.62M +4.8% Jun 30, 2015 10-K 2016-09-16
Q1 2015 57.2M +2.61M +4.79% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 56.6M +6.52M +13% Dec 31, 2014 10-Q/A 2015-02-25
Q3 2014 56.5M +6.51M +13% Sep 30, 2014 10-Q/A 2015-02-23
Q2 2014 54.6M +7.59M +16.2% Jun 30, 2014 10-K 2015-09-14
Q1 2014 54.5M -110M -66.9% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 50M -111M -68.9% Dec 31, 2013 10-Q 2014-02-14
Q3 2013 50M -108M -68.4% Sep 30, 2013 10-Q/A 2013-11-18
Q2 2013 47M +2.57M +5.77% Jun 30, 2013 10-K/A 2015-02-23
Q1 2013 165M +10.9M +7.1% Mar 31, 2013 10-Q/A 2013-05-20
Q4 2012 161M +11.1M +7.44% Dec 31, 2012 10-Q/A 2013-02-22
Q3 2012 158M +12.6M +8.66% Sep 30, 2012 10-Q 2012-11-19
Q2 2012 44.5M -99.1M -69% Jun 30, 2012 10-K/A 2013-10-08
Q1 2012 154M Mar 31, 2012 10-Q 2012-05-21
Q4 2011 150M Dec 31, 2011 10-Q 2012-02-14
Q3 2011 146M Sep 30, 2011 10-Q/A 2011-12-12
Q2 2011 144M Jun 30, 2011 10-K/A 2012-10-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.